Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
Real-time insight on key fixed income and fx markets.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- MNI ResearchMNI Research
Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.
- About Us
Sign up now for free access to this content.
Please enter your details below and select your areas of interest.
A narrow overnight session saw YM close -1.0, with XM unchanged vs. settlement amid a lack of broader tier 1 headline catalysts and limited activity in the U.S. Tsy space.
- Local COVID matters will continue to dominate, with suggestions in the press that NSW is conducting financial modelling for a lockdown in the Greater Sydney area through at least mid-September. There are also some suggestions that the NSW Treasurer will again request a restart of the JobKeeper scheme. The weekend also saw thousands protest the lockdowns across some of the country's major cities. Finally, Australia has signed an agreement for the purchase of 60mn additional Pfizer-BioNTech COVID vaccination doses, to be delivered in '22, and a further 25mn doses in '23, which would allow the country to conduct a vaccination "booster" scheme if needed.
- A$800mn of ACGB 1.00% 21 November 2031 supply headlines the local docket on Monday.